Christopher J. DelOrefice serves as the Executive Vice President and Chief Financial Officer at Becton, Dickinson and Company (BD), a global medical technology company. In his role, DelOrefice is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His leadership has been instrumental in driving BD's financial strategy and supporting the company's growth initiatives. Before joining BD, DelOrefice held various senior financial positions at other leading corporations. He previously served as the Senior Vice President and Chief Financial Officer at Medtronic's Minimally Invasive Therapies Group, where he played a key role in the group's financial performance and strategic planning. Prior to Medtronic, DelOrefice spent over a decade at General Electric (GE), where he held several finance leadership roles across different business units, including GE Healthcare and GE Aviation. His experience at these multinational companies has equipped him with a deep understanding of the healthcare industry and financial management on a global scale. Under DelOrefice's financial stewardship, BD has continued to strengthen its position as a leader in the medical technology sector. He has been pivotal in navigating the company through various acquisitions and integrations, ensuring that BD maintains a strong financial foundation while pursuing its mission to improve patient outcomes. DelOrefice's strategic vision and financial acumen have been crucial in helping BD achieve sustainable growth and deliver value to its shareholders.